Zuoxing Niu

2.9k total citations
40 papers, 376 citations indexed

About

Zuoxing Niu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zuoxing Niu has authored 40 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zuoxing Niu's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Zuoxing Niu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Zuoxing Niu collaborates with scholars based in China, United States and Taiwan. Zuoxing Niu's co-authors include Shengbin Shi, Quan Rao, Anqin Han, Jinming Yu, Shuqiang Zhao, Jinsong Zheng, Yibo Qin, Xiuyuan Zhang, Chuangnian Zhang and Sheng Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Zuoxing Niu

34 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuoxing Niu China 9 163 152 112 103 60 40 376
Mao Zhang China 8 191 1.2× 167 1.1× 112 1.0× 63 0.6× 23 0.4× 21 411
Davide Bosso Italy 12 133 0.8× 132 0.9× 70 0.6× 167 1.6× 25 0.4× 18 366
Xiaolong Liang China 12 179 1.1× 99 0.7× 144 1.3× 52 0.5× 36 0.6× 36 381
Sebastian Ebel Germany 10 126 0.8× 163 1.1× 111 1.0× 83 0.8× 40 0.7× 33 363
Francesca Sparano Italy 9 113 0.7× 219 1.4× 65 0.6× 103 1.0× 41 0.7× 19 369
Yulin Tan China 11 94 0.6× 162 1.1× 85 0.8× 139 1.3× 73 1.2× 29 399
Gennaro Palmiotti Italy 9 74 0.5× 163 1.1× 61 0.5× 105 1.0× 33 0.6× 22 332
Yiming Mao China 12 122 0.7× 145 1.0× 90 0.8× 243 2.4× 92 1.5× 41 479
Yiming Zhao China 10 122 0.7× 131 0.9× 64 0.6× 72 0.7× 62 1.0× 19 293
Louqian Zhang China 11 149 0.9× 147 1.0× 53 0.5× 139 1.3× 47 0.8× 23 406

Countries citing papers authored by Zuoxing Niu

Since Specialization
Citations

This map shows the geographic impact of Zuoxing Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoxing Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoxing Niu more than expected).

Fields of papers citing papers by Zuoxing Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuoxing Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoxing Niu. The network helps show where Zuoxing Niu may publish in the future.

Co-authorship network of co-authors of Zuoxing Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Zuoxing Niu. A scholar is included among the top collaborators of Zuoxing Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuoxing Niu. Zuoxing Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Niu, Zuoxing, Bo Zheng, Ya Gao, et al.. (2025). Application and Mechanism of Bionic Leaf Vein Chip in the Construction of Bioartificial Kidney. American Journal of Transplantation. 25(8). S316–S316. 1 indexed citations
4.
Huang, Yang, Junjie Jin, Ning-Chen Sun, et al.. (2025). The Mini-SiTian Array: White Paper. Research in Astronomy and Astrophysics. 25(4). 44009–44009. 3 indexed citations
5.
Niu, Zuoxing, Bin Zheng, Tuo Wei, et al.. (2025). PHLDA1 Exacerbates Renal Ischemia-Reperfusion Injury by Suppressing Fatty Acid β-Oxidation via the PPARγ/CPT1a Pathway. American Journal of Transplantation. 25(8). S569–S569.
6.
Mai, Gang, Meng Tang, Zuoxing Niu, et al.. (2025). Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysis. npj Precision Oncology. 9(1). 299–299.
7.
8.
Zhang, Panpan, Jifang Gong, Zuoxing Niu, et al.. (2024). Tinengotinib (TT-00420) in combination with atezolizumab in Chinese patients (pts) with biliary tract carcinoma (BTC): Preliminary efficacy and safety results from a phase Ib/II study.. Journal of Clinical Oncology. 42(3_suppl). 473–473. 1 indexed citations
9.
Hao, Jihui, Zheng Li, Jieer Ying, et al.. (2024). Safety and efficacy of IBI389, an anti-CLDN18.2/CD3 bispecific antibody, in patients with advanced pancreatic ductal adenocarcinoma: Preliminary results from a phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 4011–4011. 8 indexed citations
10.
Sun, Hongfu, Wenfeng Yang, Haiqun Lin, et al.. (2024). A Phase 1b Clinical Trial of Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer. International Journal of Radiation Oncology*Biology*Physics. 119(3). 896–901. 5 indexed citations
11.
Xu, Jianming, Jianping Xiong, Shanzhi Gu, et al.. (2023). A phase 2 study of HMPL-453, a selective FGFR tyrosine kinase inhibitor (TKI), in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions.. Journal of Clinical Oncology. 41(16_suppl). e16118–e16118. 1 indexed citations
12.
13.
Shen, Lin, Ken Kato, Sung‐Bae Kim, et al.. (2021). RATIONALE 302: Randomized, phase 3 study of tislelizumab versus chemotherapy as second-line treatment for advanced unresectable/metastatic esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 39(15_suppl). 4012–4012. 34 indexed citations
14.
Shi, Runjie, et al.. (2020). Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study. SHILAP Revista de lepidopterología.
15.
Lim, Ho Yeong, Yi‐Hsiang Huang, Guoliang Shao, et al.. (2020). 1009P Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study. Annals of Oncology. 31. S699–S699. 4 indexed citations
16.
Tang, Wei, Pao Xu, Hong Wang, et al.. (2018). MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Niu, Zuoxing. (2013). Anti-tumor effect of brucine. Zhonghua zhongliu fangzhi zazhi. 2 indexed citations
18.
Gao, Jie, Rongrong Zhao, Yan Xue, et al.. (2013). Role of enolase-1 in response to hypoxia in breast cancer: Exploring the mechanisms of action. Oncology Reports. 29(4). 1322–1332. 40 indexed citations
19.
Shi, Shengbin, et al.. (2012). Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer. Pancreatology. 12(6). 475–479. 14 indexed citations
20.
Niu, Zuoxing, et al.. (2009). The Histological Origin of Solid-Pseudopapillary Neoplasm of the Pancreas. 3(1). 13–18. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mao Zhang Breakdown of academic impact, for papers by Davide Bosso Breakdown of academic impact, for papers by Xiaolong Liang Breakdown of academic impact, for papers by Sebastian Ebel Breakdown of academic impact, for papers by Francesca Sparano Breakdown of academic impact, for papers by Yulin Tan Breakdown of academic impact, for papers by Gennaro Palmiotti Breakdown of academic impact, for papers by Yiming Mao Breakdown of academic impact, for papers by Yiming Zhao Breakdown of academic impact, for papers by Louqian Zhang
Rankless by CCL
2026